Trident Lifeline has made further Investment by acquiring an additional equity stake of 9.04% of Trident Mediquip (TML), a subsidiary company from existing shareholders of the Company. Pursuant to the above, the shareholding of the company in TML has increased from 51% to 60.04%. Cost of acquisition is around Rs 4.42 crore.
Trident Lifeline is engaged in the pharmaceutical business ethical marketing in domestic as well as international market.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1830.10 |
| Dr. Reddys Lab | 1283.45 |
| Cipla | 1339.20 |
| Zydus Lifesciences | 923.00 |
| Lupin | 2386.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: